Stay updated with breaking news from Transcode Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Dow Jones closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 27,100 shares, an increase of 22.1% from the May 15th total of 22,200 shares. Currently, 4.4% of the shares of the stock are sold short. Based on […]
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Rating) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 27,100 shares, a growth of 22.1% from the May 15th total of 22,200 shares. Based on an average daily trading volume, of 162,200 shares, the days-to-cover ratio […]
The Dow Jones closed higher by over 140 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Rating) CEO Robert Michael Dudley purchased 19,000 shares of the firm’s stock in a transaction that occurred on Friday, June 9th. The stock was acquired at an average price of $2.76 per share, with a total value of $52,440.00. Following the completion of the purchase, the chief executive officer […]